Home > Legislation > 115th Congress > H.R.5582

H.R.5582 - Abuse Deterrent Access Act of 2018115th Congress (2017-2018) |

Bill

Hide Overview
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 04/23/2018)
Committees: House - Energy and Commerce; Ways and Means | Senate - Finance
Committee Reports: H. Rept. 115-721
Latest Action: Senate - 06/13/2018 Received in the Senate and Read twice and referred to the Committee on Finance.  (All Actions)

Tracker:

This bill has the status Passed House

Here are the steps for Status of Legislation:

  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [1]

Subject — Policy Area:

Summary: H.R.5582 — 115th Congress (2017-2018)All Information (Except Text)

Bill summaries are authored by CRS.

Shown Here:
Passed House amended (06/12/2018)

Abuse Deterrent Access Act of 2018

(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.